A womb cancer drug has shocked experts with how effective it is against colorectal tumours, after it seemingly cured every patient in a trial.
The antibody therapy Dostarlimab, already approved for women in the UK, smashed expectations in a study at Memorial Sloan Kettering Cancer Center in New York.
All 18 colorectal cancer patients involved in the trial were still in remission one year after it finished, with no signs of tumour reformation.
Researchers said there were ‘a lot of happy tears’ among the participants. All 18 had been unsuccessfully treated with traditional therapies before signing up to the study.
While the trial was small, it sets up Dostarlimab as a potential cure for one of the most deadly common cancers.
Dr Luis Diaz, one of the lead researchers of the trial, said: ‘I believe this is the first time this has happened in the history of cancer. It’s really exciting. I think this is a great step forward for patients.’
Colorectal, or bowel, cancer, is the second most common cause of cancer deaths in the US, taking 50,000 lives a year. In the UK, around 16,000 Britons die each year.
There is no specific treatment for the disease, with patients reliant on surgery to remove tumours and chemo or radiotherapy to keep it away.
However, Dostarlimab — made by the British pharmaceutical giant GlaxoSmithKline — only works on a fraction of patients.
I hope so now maybe they can fix our crappy healthcare system
bet drug companies and FDA cant wait to get their fingers in this
bet drug companies and FDA cant wait to get their fingers in this It might cure something but you wont be able to afford it
Agree, no one will be able to afford it but yet the covid vacc is free
Mark Cuban will Have His Medicine Facility Open Up Soon Enough …Bye Bye Robbing Medicine People And Control Gov !